Joseph W. Laplume serves as EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). Laplume has reported 11 insider filings with the SEC since 2025. The most recent filing was in June 2026.
Every role Joseph W. Laplume has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)2 filingsUpdated Aug 31, 2026
Joseph W. Laplume is EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). 12 SEC Form 4 filings on record going back to 2025, most recently on 11 August 2026. Most recent open-market trade: bought $4K of CRL on 4 March 2026. Lifetime open-market purchases: $4K. Lifetime open-market sales: $324K.
Every recent SEC Form 4 transaction Joseph W. Laplume has reported, most recent first.
InsiderAlpha's records for Joseph W. Laplume go back to 2025: 12 primary Form 4 filings, an average of 6.0 per year. The typical open-market purchase is $4K (1 buy totaling $4K). The largest single buy on record is $4K of CRL in 2026. Sales side: 4 recorded sales totaling $324K, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Joseph W. Laplume files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Joseph W. Laplume is a corporate insider, tracked as EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchase ($4K) and 4 open-market sales ($324K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.744 shares @ $180.71$134K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.185 shares @ $156.73$29K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.243 shares @ $160.30$39K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.1.7K shares @ $211.68$370K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.155 shares @ $135.63$21K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.83 shares @ $138.65$12K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.122 shares @ $136.73$17K
$CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.161 shares @ $136.73$22K